Group name
S-RARPĀ
Continence
35 (58.3%)
p-value
1
remark
Urinary continence
Sexual function
14 (10, 18)
p-value
1
remark
IIEF-5 score,median (IQR)
PSA
0.045 (0.026)
p-value
1
remark
postoperative total PSA, ng/mL
Follow Up Time
Postoperative 3 months